Quantification of N-acetyl-seryl-aspartyl-lysyl-proline in hemodialysis patients administered angiotensin-converting enzyme inhibitors by stable isotope dilution liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 54, Issue 4, 2011, Pages 765-771

  Inoue, Koichi ^a   Ikemura, Ayaka ^a   Tsuruta, Yoshinari ^b   Watanabe, Kazuki ^c   Tsutsumiuchi, Kaname ^c   Hino, Tomoaki ^a   Oka, Hisao ^a  

^a KINJO GAKUIN UNIVERSITY   (Japan)

^b Meiyo Clinic   (Japan)

^c CHUBU UNIVERSITY   (Japan)

Author keywords

Ac ADKP; Angiotensin converting enzyme (ACE) inhibitors; Hemodialyzed subjects; Liquid chromatography tandem mass spectrometry (LC MS MS); N acetyl seryl aspartyl lysyl proline (Ac SDKP)

Indexed keywords

ENALAPRIL; ION; SERASPENIDE; STABLE ISOTOPE; TRANDOLAPRIL;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HEMODIALYSIS PATIENT; HUMAN; ISOTOPE DILUTION ASSAY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBON ISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEUTERIUM; DRUG MONITORING; FEMALE; HUMANS; HYPERTENSION; INDICATOR DILUTION TECHNIQUES; MALE; MIDDLE AGED; NITROGEN ISOTOPES; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RENAL DIALYSIS; RENAL INSUFFICIENCY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; THYMOSIN;

EID: 78650231992     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.10.009     Document Type: Article

References (19)

1. Lenfant M., Wdzieczak-Bakala J., Guittet E., Prome J.C., Sotty D., Frindel E. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:779-782.
2. Wdzieczak-Bakala J., Fache M.P., Lenfant M., Frindel E., Sainteny F. AcSDKP, an inhibitor of CFU-S proliferation, is synthesized in mice under steady-state conditions and secreted by bone marrow in long-term culture. Leukenia 1990, 4:235-237.
3. Grillon C, Rieger K., Bakala J., Schott D., Morgat J.L., Hannappel E., Voelter W., Lenfant M. Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system. FEBS Lett. 1990, 274:30-34.
4. Carvasin M.A., Rhaleb N.E., Yang X.P., Carretero O.A. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension 2004, 43:1140-1145.
5. Azizi M., Ezan E., Nicolet L., Grognet J.M., Menard J. High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 1997, 30:1015-1019.
6. Azizi M., Ménard J., Peyrard S., Lièvre M., Marre M., Chatellier G. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the noninsulin-dependent diabetes, hypertension, microalbuminuria, proteinuria, cardiovascular events, and ramipril study. Diabetes Care 2006, 29:1331-1336.
7. Sharma U., Rhaleb N.E., Pokharel S., Harding P., Rasoul S., Peng H., Carretero O.A. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1226-H1232.
8. Lin C.X., Rhaleb N.E., Yang X.P., Liao T.D., D'Ambrosio M.A., Carretero O.A. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1253-1261.
9. Liu J.M., Kusinski M., Ilic V., Bignon J., Hajem N., Komorowski J., Kuzdak K., Stepien H., Wdzieczak-Bakala J. Overexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors. Anticancer Res. 2008, 28:2813-2817.
10. Messerli F.H. The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point. J. Am. Coll. Cardiol. 2009, 53:468-470.
11. Pradelles P., Frobert Y., Créminon C., Liozon E., Massé A., Frindel E. Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay. Biochem. Biophys. Res. Commun. 1990, 170:986-993.
12. Pradelles P., Frobert Y., Créminon C., Ivonine H., Frindel E. Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues. FEBS Lett. 1991, 289:171-175.
13. Junot C., Theodoro F., Thierry J., Clement G., Wdzieczak-Bakala J., Ezan E. Development of an enzyme immunoassay for a stable amidated analog of the hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro. J. Immunoassay Immunochem. 2001, 22:15-31.
14. Junot C., Pruvost A., Créminon C., Grognet J.M., Benech H., Ezan E. Characterization of immunoreactive acetyl-Ser-Asp-Lys-Pro in human plasma and urine by liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B 2001, 752:69-75.
15. Thierry J., Papet M.P., Servent N.S., Haumont J.P., Potier P., Lenfant M. Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation. J. Med. Chem. 1990, 33:2122-2127.
16. Barlos K., Gatos D., Schäfer W. Synthesis of prothymosin (ProT) - a protein consisting of 109 amino acid residues. Angew. Chem. Int. Ed. Engl. 1991, 30:590-593.
17. FDA Guidance for Industry. Bioanalytical Method Validation. US Department of Health and Human Services, FDA, CDER, CVM, 2001; http://www.fda.gov/cder/guidance/indeex.htm.
18. van der Meer P., Lipsic E., Westenbrink B.D., van de Wal R.M., Schoemaker R.G., Vellenga E., van Veldhuisen D.J., Voors A.A., van Gilst W.H. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 2005, 112:1743-1747.
19. Meur Y.L., Lorgeot V., Comte L., Szelag J.C., Aldigier J.C., Leroux-Robert C., Praloran V. Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements. Am. J. Kidney Dis. 2001, 38:510-517.